Pharma Mar (MEX:PHM1N) Other Stockholders Equity: MXN1 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:PHM1N Pharma Mar SA MEX:PHM1N
68 GF Score
Price MXN1,608.38
GF Value MXN1,734.34
! 2 Warning Signs
View Full Analysis

What is Pharma Mar Other Stockholders Equity?

Pharma Mar MEX:PHM1N 68 Other Stockholders Equity is MXN1 Mil as of Jun. 2026. GuruFocus rates MEX:PHM1N with a GF Score™ of 68/100 and a GF Value™ of MXN1,734.34. The stock has 2 warning signs investors should review.

Pharma Mar's Other Stockholders Equity for the quarter that ended in Jun. 2026 was MXN1 Mil.

Pharma Mar's quarterly Other Stockholders Equity increased from Dec. 2025 (MXN0 Mil) to Mar. 2026 (MXN1 Mil) and increased from Mar. 2026 (MXN1 Mil) to Jun. 2026 (MXN1 Mil).

Pharma Mar's annual Other Stockholders Equity increased from Dec. 2023 (MXN0 Mil) to Dec. 2024 (MXN0 Mil) and increased from Dec. 2024 (MXN0 Mil) to Dec. 2025 (MXN0 Mil).

Pharma Mar Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Pharma Mar's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar Other Stockholders Equity Chart

Pharma Mar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.39 0.28 0.35 0.38

Pharma Mar Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.32 0.38 0.50 0.52
MEX:PHM1N
68GF Score
Pharma Mar SA MEX:PHM1N
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Mar Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of MXN1 Mil mean?
Pharma Mar (MEX:PHM1N) has a Other Stockholders Equity of MXN1 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Pharma Mar and its competitors.
Is Pharma Mar's Other Stockholders Equity too high?
Pharma Mar's current Other Stockholders Equity is MXN1 Mil. Overall, Pharma Mar has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Pharma Mar's Other Stockholders Equity compare to VRTX and REGN?
Pharma Mar's Other Stockholders Equity of MXN1 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Pharma Mar and its competitors. Pharma Mar's current Other Stockholders Equity is MXN1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Mar stock overvalued right now?
Pharma Mar (MEX:PHM1N) has a current Other Stockholders Equity of MXN1 Mil. The stock's GF Value™ is MXN1,734.34, compared to a current price of MXN1,608.38 — trading 7.3% below its estimated fair value. The current Other Stockholders Equity is MXN1 Mil. Pharma Mar's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Pharma Mar (MEX:PHM1N), the current Other Stockholders Equity is MXN1 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Mar (MEX:PHM1N) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of MXN1,608.38 is trading 7.3% below its estimated GF Value™ of MXN1,734.34.

Key valuation signals for MEX:PHM1N:

  • Other Stockholders Equity: MXN1 Mil
  • GF Value™: MXN1,734.34 vs. price of MXN1,608.38 (7.3% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the MEX:PHM1N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
68GF Score

Get the complete analysis for MEX:PHM1N

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,608.38
Price
MXN1,734.34
GF Value